CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors
Clinical trial NCT04702841 · UNKNOWN
Trial details
- NCT number
- NCT04702841
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2022-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.